London Daily

Focus on the big picture.
Thursday, Oct 23, 2025

Ignore the pessimism: Covid vaccines are quietly prevailing

Ignore the pessimism: Covid vaccines are quietly prevailing

Nightmare scenarios involving deadly new variants are making us all too gloomy – but there’s a scientific case for optimism
It can be quite easy, reading the press, to believe that the pandemic will never end. Even when good news about vaccines started to arrive in the autumn, this grim narrative managed to harden. In the past month, you could read “five reasons that herd immunity is probably impossible”, even with mass vaccination; breathless reports about yet-uncharacterised but potentially ruinous variants, such as the “double mutant” variant in India, or two concerning variants potentially swapping mutations and teaming up in a “nightmare scenario” in California; get ready, some analysts said, for the “permanent pandemic”.

Among many people I know, a sort of low-grade doom has set in. They think the vaccines are a mere sliver of hope, only holding back the virus for a short time before being worn down by a rush of ever-cleverer variants that will slosh around us, perhaps for ever. Things might briefly get better, they believe, but only by a little, and even that is tenuous.

However despite such dark talk, and the potential difficulties along the way of vaccine rollout, I still remain optimistic. Since about the midway point of last year I have believed that extremely potent vaccines are going to end the pandemic. They’ll do so by either driving the disease down to near-extinction, or so constraining its force and spread that it becomes a manageable concern, like measles or mumps. I actually think this will happen fairly soon, as long as we get everyone – the whole world, not just the rich – vaccinated.

The scientific case for optimism is straightforward. The vaccines we have are beyond very good, they’re among the most effective ever created. They appear to be potent in real-life situations, and results so far show that protection is long-lasting. Crucially, new results in the US show that the mRNA vaccines used there effectively prevented coronavirus infections – not just serious symptoms – in results similar to those previously reported by a UK-based study. And another study in the UK suggested that vaccinated groups were less likely to spread coronavirus infection overall. This is exactly what we need to choke out the pandemic: vaccines that don’t just protect, but actually halt the virus infecting people and spreading.

When it comes to variants, it is clear that some are more infectious, and some are more deadly. But their interaction with vaccines isn’t yet clear. Some lab-based results show that certain viral mutations may make some immune responses less potent. And one study suggested the Oxford/AstraZeneca vaccine might be less potent against the South African variant. But the majority of scientists believe that vaccines have so far held the line, and will continue to do so. If variants continue to make small advances, vaccines can be updated. A doomsday strain may be possible, but exceedingly hard to predict. Evolution isn’t an on-demand miracle worker for viral supremacy; even over decades most viruses don’t escape vaccine protection.

The stories suggesting a dismal and dangerous future aren’t wrong, per se. There is clearly a long way to go in ending the pandemic. A few pieces are sensationalistic (some scientists have taken to calling the rolling panics accompanying each new mutation “scariants” or “mutant porn”), but most are good-faith reporting of what experts say, or attempts to tune public discourse away from naive false hopes (most articles) or, more rarely, away from miserable and abject doom (this article).

What they do, in aggregate, is try to describe the future in a time of incredible uncertainty. And, as a rule, we’re quite bad at dealing with uncertainty. During the pandemic the public sphere sometimes appears to be in the middle of a full-blown epistemic crisis over this, with wildly different claims about what “the science” portends. The truth is that the science we see now is itself uncertain. It’s not a process of years-long studies that provide near-definitive answers. We’re all mucking about behind the scientific curtain, looking at science as it’s being done; at inferences and hypotheses; incomplete and ongoing studies. Often, what is parsed publicly these days as “science” is just informed guesses by experts.

This can pile up and become paralysing. Especially since the pandemic itself exploded our horizon for negative possibilities. It seems like each day there there are a thousand new paths the future might take, and no way to know how solid each might actually be. Even more, as each piece of good news comes freighted with new caveats and doomsday scenarios, it can feel like things are nearly as uncertain now as they were at the beginning of the crisis. Like everything we know could suddenly and radically shift, the same way it did last March.

That isn’t the case. There are two massive and opposing fronts of uncertainty facing us. We don’t yet know for certain if vaccines will effectively halt transmission. On this, we have some indication that it looks good, and conclusive answers are coming. And we don’t know what (terrible) variants might yet emerge. But even though that unknown seems massive, variants aren’t some immunological antimatter destined to suddenly and totally vaporise the vaccines.

Seen this way, the possibilities don’t look so grim. Early in the pandemic we had nothing, the timeline for vaccines and whether they would work was uncertain, the outside chance was that they would take years, or they would fail. The horizon was the virus, and just how bad it could get. Now the vaccines are the horizon, and it is the virus that has only the outside chance to delay or disrupt our path there.
Newsletter

Related Articles

0:00
0:00
Close
US Administration Under President Donald Trump Reportedly Lifts Ban on Ukraine’s Use of Storm Shadow Missiles Against Russia
‘Frightening’ First Night in Prison for Sarkozy: Inmates Riot and Shout ‘Little Nicolas’
White House Announces No Imminent Summit Between Trump and Putin
US and Qatar Warn EU of Trade and Energy Risks from Tough Climate Regulation
Apple Challenges EU Digital Markets Act Crackdown in Landmark Court Battle
Nicolas Sarkozy begins five-year prison term at La Santé in Paris
Japan stocks surge to record as Sanae Takaichi becomes Prime Minister
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
×